Page last updated: 2024-08-25

fangchinoline and Bone Cancer

fangchinoline has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, W; He, W; Jin, S; Li, J; Li, X; Lu, X; Qian, Y; Yang, W; Yang, Z	1

Other Studies

1 other study(ies) available for fangchinoline and Bone Cancer

Article	Year
Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways. International journal of molecular medicine, 2017, Volume: 40, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Bone Neoplasms; Carcinogenesis; Cell Movement; Cell Proliferation; Drugs, Chinese Herbal; Female; Humans; Mice, Inbred BALB C; Neoplasm Invasiveness; Osteosarcoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction	2017

Article

Year

Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways.

International journal of molecular medicine, 2017, Volume: 40, Issue:2

Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Bone Neoplasms; Carcinogenesis; Cell Movement; Cell Proliferation; Drugs, Chinese Herbal; Female; Humans; Mice, Inbred BALB C; Neoplasm Invasiveness; Osteosarcoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction

2017